NYSE:A - Agilent Technologies Stock Price, Forecast & News

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies declared a quarterly dividend on Wednesday, November 20th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.18 per share on Wednesday, January 22nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date of this dividend is Monday, December 30th. This is an increase from Agilent Technologies's previous quarterly dividend of $0.16. View Agilent Technologies' Dividend History.

Agilent Technologies declared that its board has authorized a share buyback plan on Monday, November 19th 2018, which permits the company to buyback $1,750,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 8.8% of its shares through open market purchases. Shares buyback plans are often a sign that the company's management believes its shares are undervalued.

Agilent Technologies Inc (NYSE:A) issued its earnings results on Monday, November, 25th. The medical research company reported $0.89 EPS for the quarter, beating analysts' consensus estimates of $0.86 by $0.03. The medical research company had revenue of $1.37 billion for the quarter, compared to analysts' expectations of $1.33 billion. Agilent Technologies had a return on equity of 20.13% and a net margin of 20.74%. The company's revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.81 EPS. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Agilent Technologies.

Agilent Technologies updated its FY20 earnings guidance on Monday, November, 25th. The company provided EPS guidance of $3.38-3.43 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.44. The company issued revenue guidance of $5.50-5.55 billion, compared to the consensus revenue estimate of $5.55 billion.

13 brokers have issued twelve-month target prices for Agilent Technologies' stock. Their forecasts range from $76.00 to $100.00. On average, they anticipate Agilent Technologies' share price to reach $85.31 in the next year. This suggests that the stock has a possible downside of 5.5%. View Analyst Price Targets for Agilent Technologies.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.

News articles about A stock have been trending negative on Wednesday, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Agilent Technologies earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned media stories about the medical research company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Agilent Technologies.

Agilent Technologies saw a decline in short interest in December. As of December 31st, there was short interest totalling 4,660,000 shares, a decline of 9.2% from the December 15th total of 5,130,000 shares. Based on an average daily trading volume, of 1,570,000 shares, the days-to-cover ratio is presently 3.0 days. Currently, 1.5% of the shares of the stock are short sold. View Agilent Technologies' Current Options Chain.

Some companies that are related to Agilent Technologies include Thermo Fisher Scientific (TMO), Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include AbbVie (ABBV), NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), Netflix (NFLX), Walt Disney (DIS), Boeing (BA), Paypal (PYPL), Gilead Sciences (GILD) and Intel (INTC).

Agilent Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include LGT Capital Partners LTD. (0.19%), Calamos Advisors LLC (0.16%), Hexavest Inc. (0.15%), Zurcher Kantonalbank Zurich Cantonalbank (0.13%), Hahn Capital Management LLC (0.12%) and Commerzbank Aktiengesellschaft FI (0.06%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank, State of Alaska Department of Revenue, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Boston Trust Walden Corp, Janney Montgomery Scott LLC, Hahn Capital Management LLC, Sciencast Management LP and Calamos Advisors LLC. Company insiders that have sold Agilent Technologies company stock in the last year include Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

A stock was purchased by a variety of institutional investors in the last quarter, including Hexavest Inc., Artemis Investment Management LLP, PGGM Investments, LGT Capital Partners LTD., Johanson Financial Advisors Inc., S.E.E.D. Planning Group LLC, Krueger & Catalano Capital Partners LLC and Exchange Traded Concepts LLC. View Insider Buying and Selling for Agilent Technologies.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of A stock can currently be purchased for approximately $90.32.

Agilent Technologies has a market capitalization of $28.01 billion and generates $5.16 billion in revenue each year. The medical research company earns $1.07 billion in net income (profit) each year or $3.11 on an earnings per share basis. Agilent Technologies employs 16,300 workers across the globe.View Additional Information About Agilent Technologies.

The official website for Agilent Technologies is http://www.agilent.com/.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 800-227-9770 or via email at [email protected]